MIDAZOLAM HYDROCHLORIDE
- Product NDC
- 51754-2130
- 11-digit product format
- 517542130
- Labeler code
- 51754
- Product ID
- 51754-2130_5aa322a4-0b10-4f41-ba56-508fc2b25229
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MIDAZOLAM HYDROCHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Exela Pharma Sciences, LLC
- Application
- NDA215868
- Marketing category
- NDA
- Marketing start
- 2022-12-01
- Marketing end
- 0000-00-00
- Substance
- MIDAZOLAM HYDROCHLORIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51754-2130 | MIDAZOLAM HYDROCHLORIDE INJECTION, SOLUTION [EXELA PHARMA SCIENCES, LLC] | 2 | Legacy NDC | 20221217_7b42059c-16ad-4826-829b-83b42a39435b.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51754-2130-4 | 51754213004 | 25 VIAL in 1 CARTON (51754-2130-4) > 50 mL in 1 VIAL | 25 vial | 2022-12-01 | 0000-00-00 | No | No | Current |